Market Tracker

08/20 8:24am ET

Ligand Pharmaceuticals Inc (NASDAQ:LGND)

55.30
Data as of Aug 19
 -2.65 / -4.57%
Today’s Change
39.75
Today|||52-Week Range
80.42
+5.13%
Year-to-Date

Today’s Trading

Previous close57.95
Today’s open57.80
Day’s range-- - --
Volume599,531
Average volume (3 months)380,527
Market cap$1.1B
Dividend yield--
Data as of 08/19/2014

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)+70.37%
Earnings growth (next 5 years)+30.00%
Revenue growth (last year)+56.02%
P/E ratio153.6
Price/Sales21.82
Price/Book22.81

Competitors

 Today’s
change
Today’s
% change
EPZMEpizyme Inc-0.72-2.07%
NBIXNeurocrine Bioscienc...-0.18-1.17%
CBPOChina Biologic Produ...-0.03-0.07%
TSROTESARO Inc-0.14-0.46%
Data as of 08/19/2014

Financials

Next reporting dateNovember 11, 2014
EPS forecast (this quarter)$0.32
Annual revenue (last year)$49.0M
Annual profit (last year)$8.8M
Net profit margin18.03%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
John L. Higgins
Chief Operating Officer &
Executive Vice President
Matthew W. Foehr
Corporate headquarters
La Jolla, California

Forecasts